These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 35152815)
1. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance. Ashrafizadeh M; Saebfar H; Gholami MH; Hushmandi K; Zabolian A; Bikarannejad P; Hashemi M; Daneshi S; Mirzaei S; Sharifi E; Kumar AP; Khan H; Heydari Sheikh Hossein H; Vosough M; Rabiee N; Kumar Thakur V; Makvandi P; Mishra YK; Tay FR; Wang Y; Zarrabi A; Orive G; Mostafavi E Expert Opin Drug Deliv; 2022 Apr; 19(4):355-382. PubMed ID: 35152815 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Bai J; Liu Y; Jiang X Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788 [TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression. Ashrafizadeh M; Mirzaei S; Gholami MH; Hashemi F; Zabolian A; Raei M; Hushmandi K; Zarrabi A; Voelcker NH; Aref AR; Hamblin MR; Varma RS; Samarghandian S; Arostegi IJ; Alzola M; Kumar AP; Thakur VK; Nabavi N; Makvandi P; Tay FR; Orive G Carbohydr Polym; 2021 Nov; 272():118491. PubMed ID: 34420747 [TBL] [Abstract][Full Text] [Related]
6. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis. Dong K; Zhao ZZ; Kang J; Lin LR; Chen WT; Liu JX; Wu XL; Lu TL Int J Nanomedicine; 2020; 15():10285-10304. PubMed ID: 33376322 [TBL] [Abstract][Full Text] [Related]
7. A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites. Liu B; Yang W; Che C; Liu J; Si M; Gong Z; Gao R; Yang G ChemistryOpen; 2021 Apr; 10(4):408-413. PubMed ID: 33605540 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of Graphene and AuNP Core Polyaniline Shell Nanocomposites as Multifunctional Theranostic Platforms for SERS Real-time Monitoring and Chemo-photothermal Therapy. Chen H; Liu Z; Li S; Su C; Qiu X; Zhong H; Guo Z Theranostics; 2016; 6(8):1096-104. PubMed ID: 27279904 [TBL] [Abstract][Full Text] [Related]
9. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy. Miao D; Yu Y; Chen Y; Liu Y; Su G Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274 [TBL] [Abstract][Full Text] [Related]
10. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy. Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128 [TBL] [Abstract][Full Text] [Related]
11. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy. Xie M; Zhang F; Peng H; Zhang Y; Li Y; Xu Y; Xie J Colloids Surf B Biointerfaces; 2019 Apr; 176():462-470. PubMed ID: 30682619 [TBL] [Abstract][Full Text] [Related]
12. Conjugation of Doxorubicin and Carbon-based-nanostructures for Drug Delivery against HT-29 Colon Cancer Cells. Aghdam KJ; Sabeti B; Chekin F; Mashreghi M Comb Chem High Throughput Screen; 2024; 27(18):2726-2733. PubMed ID: 37605418 [TBL] [Abstract][Full Text] [Related]
13. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery. Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261 [TBL] [Abstract][Full Text] [Related]
14. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy. Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088 [TBL] [Abstract][Full Text] [Related]
15. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery. Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019 [TBL] [Abstract][Full Text] [Related]
16. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle. Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449 [TBL] [Abstract][Full Text] [Related]
17. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System. Ghamkhari A; Abbaspour-Ravasjani S; Talebi M; Hamishehkar H; Hamblin MR Int J Biol Macromol; 2021 Feb; 169():521-531. PubMed ID: 33340628 [TBL] [Abstract][Full Text] [Related]
18. PEGylated graphene oxide-capped gold nanorods/silica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness. Qi Z; Shi J; Zhang Z; Cao Y; Li J; Cao S Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109889. PubMed ID: 31499943 [TBL] [Abstract][Full Text] [Related]
19. Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. SreeHarsha N; Maheshwari R; Al-Dhubiab BE; Tekade M; Sharma MC; Venugopala KN; Tekade RK; Alzahrani AM Int J Nanomedicine; 2019; 14():7419-7429. PubMed ID: 31686814 [TBL] [Abstract][Full Text] [Related]
20. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment. Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]